Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  BET inhibitor CPI-0610
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0610-01, NCI-2014-00182, NCT01949883
A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0610-03, NCI-2014-02039, NCT02157636
A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelodysplastic/Myeloproliferative Neoplasms
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0610-02, NCI-2014-02045, NCT02158858
Start Over